Intracellular expression of CR (in particular nuclear expression of CXCR4) assessed at primary tissue level has been associated to the metastatic destination of tumor cells and to patient outcome in several different cancer entities [16-20,28-30]. The gene discussed is CXCR4; the disease is cancer.